Mid-valley Pathology — 3 certified H-1B filings (FY2023–FY2025)

2
Filings · FY2025
$300k
Median base · FY2025
Pathology Physician
Top role · 2 all-time
TX
Top state · 3 all-time
FY

Mid-valley Pathology filed 2 certified H-1B LCAs in FY2025 (up 100% from the year before), with a median base salary of $300k and the middle 50% of offers between $300k and $300k. Across all years it has 3 certified filings since FY2023, most often for Pathology Physician in Texas.

How much does Mid-valley Pathology pay H-1B workers?

Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $300k median in FY2025. Base pay only — hover a year for its figures.

$200k$220k$240k$260k$280k$300k$320k’23’25

How has Mid-valley Pathology's H-1B hiring changed by year?

1 certified filings in FY2023 → 2 in FY2025. The change column is each year against the one before.

Mid-valley Pathology certified H-1B filings and base salary by fiscal year
Fiscal yearFilingsvs prior FYMedian base
FY20252+100%$300k
FY20231—$220k

What jobs does Mid-valley Pathology sponsor for H-1B?

The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.

Mid-valley Pathology most-sponsored H-1B job titles with base-salary percentiles
Job titleFilingsMedian base
Pathology Physician2$300k
Physician (Pathologist)1$220k

Where does Mid-valley Pathology hire H-1B workers?

Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.

33Certified filings (log scale)
Mid-valley Pathology H-1B worksite states
StateFilingsMedian base
TX3$300k

What has Mid-valley Pathology filed recently?

Every certified LCA on record for Mid-valley Pathology: job title, worksite, prevailing-wage level and the offered base salary.

Mid-valley Pathology recent certified H-1B LCA filings
FYJob titleBase salary
2025Pathology Physician$300,000
2025Pathology Physician$300,000
2023Physician (Pathologist)$220,000

Common questions about Mid-valley Pathology's H-1B filings

How much does Mid-valley Pathology pay H-1B workers?
Mid-valley Pathology's median certified H-1B base salary is $300k (FY2025), from 2 filings. See the full salary distribution and percentiles above.
How many H-1B workers does Mid-valley Pathology sponsor?
Mid-valley Pathology has 3 certified H-1B Labor Condition Applications on record (FY2023–FY2025).
What jobs does Mid-valley Pathology sponsor for H-1B?
Mid-valley Pathology's most-sponsored H-1B roles include Pathology Physician, Physician (Pathologist).
Where does Mid-valley Pathology hire H-1B workers?
Mid-valley Pathology's top H-1B worksite states are TX.
Does a certified LCA mean an H-1B visa was approved?
No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
What salary do these figures show?
The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
What do prevailing-wage levels I–IV mean?
The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.

Keep exploring

Browse all sponsors →

Calculate your H-1B lottery odds →orCheck out the insights →

Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2023–FY2025). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →